---
title: "China Resources Pharma's subsidiary China Resources Jiangzhong earned 906 million RMB last year, an increase of 15%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/273607632.md"
description: "China Resources Pharma announced that its subsidiary China Resources Jiangzhong achieved a total operating revenue of RMB 4.22 billion for the fiscal year 2025, a year-on-year decrease of 4.9%. The net profit attributable to shareholders was RMB 906 million, an increase of 15%, with earnings per share of RMB 1.43"
datetime: "2026-01-25T09:47:36.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/273607632.md)
  - [en](https://longbridge.com/en/news/273607632.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/273607632.md)
---

# China Resources Pharma's subsidiary China Resources Jiangzhong earned 906 million RMB last year, an increase of 15%

China Resources Pharma (03320.HK) announced that its subsidiary China Resources Jiangzhong (600750.SH) achieved a total operating revenue of 4.22 billion RMB for the fiscal year 2025, a year-on-year decrease of 4.9%. The net profit attributable to shareholders was 906 million RMB, an increase of 15%, with earnings per share of 1.43 RMB

### Related Stocks

- [600750.CN](https://longbridge.com/en/quote/600750.CN.md)
- [03320.HK](https://longbridge.com/en/quote/03320.HK.md)

## Related News & Research

- [China Resources Pharmaceutical Completes RMB1.4 Billion Second Tranche of 2026 Bonds in China](https://longbridge.com/en/news/284352645.md)
- [China's Bio-Thera Gets US Nod for Golimumab Biosimilar](https://longbridge.com/en/news/286880573.md)
- [New York Governor Signs Bills To Preserve Mandatory Vaccines](https://longbridge.com/en/news/286947583.md)
- [09:35 ETOpen Medicine Launches Ahead of ASCO, Introducing "Living Algorithms" for Real-Time Oncology Decision-Making](https://longbridge.com/en/news/286923155.md)
- [10:03 ETVeterans United Names Best Places for Veterans to Live in 2026](https://longbridge.com/en/news/286784604.md)